<i>SERPINB9</i> is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response
Sofía Ibáñez-Molero(Oncode Institute), Daniel S. Peeper(Oncode Institute), Jean‐Christophe Marine(VIB-KU Leuven Center for Cancer Biology), Lodewyk F.A. Wessels(The Netherlands Cancer Institute), Thomas Kuilman(AstraZeneca (Netherlands)), Joyce Sanders(The Netherlands Cancer Institute), Weiwei Zhong(Bristol-Myers Squibb (United States)), Yannick Van Herck(Universitair Ziekenhuis Leuven), Alex van Vliet(The Netherlands Cancer Institute), Kim Monkhorst(The Netherlands Cancer Institute), Ewout Landeloos(VIB-KU Leuven Center for Cancer Biology), Joanna Poźniak(VIB-KU Leuven Center for Cancer Biology), Karlijn Hummelink(The Netherlands Cancer Institute), Alexandra M. Terry(Genmab (United States)), Ingrid Hofland(The Netherlands Cancer Institute), Oliver Bechter(Universitair Ziekenhuis Leuven)
Cited by 33
Related Papers
A Landscape of Pharmacogenomic Interactions in Cancer
|Cell|2016|2.3k
BRAFE600-associated senescence-like cell cycle arrest of human naevi
|Nature|2005|2.1k
The essence of senescence: Figure 1.
|Genes & Development|2010|2k